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BACKGROUND: Modifiable lifestyle factors in relation to risk for 
cardiomyopathy, a common and increasing cause of heart failure in 
the young, have not been widely studied. We sought to investigate a 
potential link between obesity, a recognized predictor of early heart 
failure, in adolescence and being diagnosed with cardiomyopathy in 
adulthood.
METHODS: This was a nationwide register-based prospective cohort 
study of 1 668 893 adolescent men (mean age, 18.3 years; SD, 0.7 years) 
who enlisted for compulsory military service from 1969 to 2005. At 
baseline, body mass index (BMI), blood pressure, and medical disorders 
were registered, along with test results for fitness and muscle strength. 
Cardiomyopathy diagnoses were identified from the National Hospital 
Register and Cause of Death Register during an up to 46-year follow-up 
and divided into categories: dilated, hypertrophic, alcohol/drug-induced, 
and other. Hazard ratios were calculated with Cox proportional hazards 
models.
RESULTS: During follow-up (median, 27 years; Q1–Q3, 19–35 years), 
4477 cases of cardiomyopathy were identified, of which 2631 (59%) 
were dilated, 673 (15%) were hypertrophic, and 480 (11%) were alcohol/
drug-induced. Increasing BMI was strongly associated with elevated risk 
of cardiomyopathy, especially dilated, starting at levels considered normal 
(BMI, 22.5–<25 kg/m2; hazard ratio, 1.38 [95% CI, 1.22–1.57]), adjusted 
for age, year, center, and baseline comorbidities, and with a >8-fold 
increased risk at BMI ≥35 kg/m2 compared with BMI of 18.5 to <20 kg/
m2. For each 1-unit increase in BMI, similarly adjusted hazard ratios were 
1.15 (95% CI, 1.14–1.17) for dilated cardiomyopathy, 1.09 (95% CI, 
1.06–1.12) for hypertrophic cardiomyopathy, and 1.10 (1.06–1.13) for 
alcohol/drug-induced cardiomyopathy.
CONCLUSIONS: Even mildly elevated body weight in late adolescence 
may contribute to being diagnosed with cardiomyopathy in adulthood. 
The already marked importance of weight control in youth is further 
strengthened by these findings, as well as greater evidence for obesity 
as a potential important cause of adverse cardiac remodeling that is 
independent of clinically evident ischemic heart disease.
© 2019 The Authors. Circulation is 
published on behalf of the American 
Heart Association, Inc., by Wolters 
Kluwer Health, Inc. This is an open 
access article under the terms of 
the Creative Commons Attribution 
Non-Commercial-NoDerivs License, 
which permits use, distribution, and 
reproduction in any medium, provided 
that the original work is properly cited, 
the use is noncommercial, and no 
modifications or adaptations are made.
Josefina Robertson, MD
Maria Schaufelberger, 
MD, PhD
Martin Lindgren, MD, PhD
Martin Adiels, PhD
Linus Schiöler, PhD
Kjell Torén, MD, PhD
John McMurray, MD, PhD
Naveed Sattar, MD, PhD
Maria Åberg, MD, PhD
Annika Rosengren, MD, 
PhD
ORIGINAL RESEARCH ARTICLE
Higher Body Mass Index in Adolescence 
Predicts Cardiomyopathy Risk in Midlife
Long-Term Follow-Up Among Swedish Men
https://www.ahajournals.org/journal/circ
Circulation
March142019
D
ow
nloaded from
 http://ahajournals.org by on June 14, 2019
Robertson et al Body Mass Index in Adolescence and Cardiomyopathy
xxx xxx, 2019 Circulation. 2019;139:00–00. DOI: 10.1161/CIRCULATIONAHA.118.0391322
OR
IG
IN
AL
 R
ES
EA
RC
H 
AR
TI
CL
E
Heart failure among young people is rare, but in contrast to decreasing incidence rates over-all, some studies have found increasing rates 
among younger people.1,2 Although coronary heart 
disease and hypertension are the most frequent causes 
of heart failure in older patients, cardiomyopathy is a 
more common underlying condition in the young. The 
incidence of hospitalizations for heart failure associat-
ed with cardiomyopathy in Sweden more than doubled 
from 1987 to 2006.1
The classification of cardiomyopathy is challenging 
because of the marked heterogeneity and differences in 
definitions over the years. The latest classification from 
the European Society of Cardiology,3 from 2008, defines 
cardiomyopathy as “a myocardial disease in which the 
heart muscle is structurally and functionally abnormal, 
in the absence of coronary artery disease, hypertension, 
valvular disease and congenital heart disease sufficient 
to cause the observed myocardial abnormality.” Five 
categories are presented; dilated, hypertrophic, restric-
tive, arrhythmogenic right ventricular, and unclassified 
cardiomyopathy. In a validation study of cardiomyopa-
thy diagnoses in the Swedish National Hospital Reg-
ister, dilated cardiomyopathy was the most common 
diagnosis (67%), followed by hypertrophic cardiomy-
opathy (16%), whereas other types were rare.4 Modifi-
able causes listed for dilated cardiomyopathy include 
myocarditis, drugs, alcohol, endocrine disorders, and 
nutritional deficiencies,3 with ≈25% estimated to have 
genetic causes resulting from specific genetic defects 
linked to cardiac muscle development.5 Hypertrophic 
cardiomyopathy is mostly a familial dominant inherit-
able disease,6 with obesity and athletic training listed as 
potential acquired causes.3
A strong link has been identified between adoles-
cent obesity and early heart failure.7 Given the overall 
increase in body weight in young people in Sweden8 
and globally,9 coinciding with the rise in individuals 
being diagnosed with cardiomyopathy in the Swedish 
population, we hypothesized that there might be an as-
sociation between adiposity (as measured by body mass 
index [BMI]) and cardiomyopathy. We identified only 1 
previous study that investigated this potential link.10 In 
this study, a range of early cardiovascular deaths were 
analyzed, among which 121 were rated as being from 
cardiomyopathies, with a 4-fold increase in risk of 
death attributed to cardiomyopathy among obese ado-
lescents relative to those with a BMI from 18.5 to <22 
kg/m2. The obese category had only 6 deaths, however, 
and the validity of the diagnosis was not specified. Ac-
cordingly, it was not possible to investigate either the 
association with severe obesity, which forms an increas-
ing proportion among the overweight,11 or the associa-
tion with obesity on specific cardiomyopathies. Diagno-
ses of different types of cardiomyopathy in the Swedish 
National Hospital Register have been shown to be accu-
rate in at least 85% of cases.4 In the present study, we 
set out to investigate the risk of specific types of cardio-
myopathy across categories of BMI in late adolescence.
METHODS
The raw data for our estimates are potentially identifiable, 
and access to those data is restricted. Researchers wishing 
to access the individual-level data need to apply for permis-
sion through a Research Ethics Board and from the primary 
data owners: the Swedish National Board of Health and 
Welfare, Statistics Sweden, and the Swedish Military Service 
Conscription Register.
Study Population
A cohort of young individuals who enlisted for military ser-
vice between 1969 and 2005 was extracted from the Swedish 
Military Service Conscription Register (n=1 886 542). Except 
for those in prison and those with severe medical conditions 
or functional disabilities (2%–3% annually), this was com-
pulsory until 2005. Women enlisting during this period were 
excluded from the study (n=10 228). After exclusions, mainly 
men with missing height or weight data (n=151 434), 1 668 
893 conscripts were included in the study (Figure I in the 
online-only Data Supplement).
All men underwent standardized examinations at 6 cen-
ters, which included measurement of weight, height, and 
blood pressure and recording of medical conditions. A psy-
chologist evaluated psychiatric symptoms, including alcohol 
and drug abuse disorders, during a structured interview; if 
present, the psychiatric symptoms were evaluated by a physi-
cian and coded according to the International Classification of 
Diseases. Cardiorespiratory fitness was evaluated by a bicycle 
ergometric test, with the final work rate (Wmax) divided by 
Clinical Perspective
What Is New?
• Cardiomyopathies have often been seen as mostly 
genetic in origin, and potentially modifiable causes 
have not been widely studied.
• We followed up a large number of adolescent 
men, some of whom were subsequently diagnosed 
with cardiomyopathy, and identified a strong link 
to overweight and obesity.
What Are the Clinical Implications?
• Given the overall increase in body weight in young 
people globally, physicians need to be aware of an 
increased risk for cardiomyopathy.
• The already marked importance of weight control 
in youth is further strengthened by these findings, 
as well as more evidence for obesity as a potential 
important cause of adverse cardiac remodeling that 
is independent of clinically evident ischemic heart 
disease.
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body weight. Raw data of Wmax per kilogram were available 
for the conscription years 1972 to 2005. For the first years 
(1969–1971), raw data were not recorded into data files, but 
the values of Wmax per kilogram were directly converted into 
9 levels that were digitized and served as a measure of fit-
ness.12–14 For conscription years 2000 to 2005, no raw data 
were recorded from conscripts performing the lowest 3 levels 
of fitness; thus, these levels were missing during this period. 
Isometric muscle strength was measured by knee extension, 
elbow flexion, and hand grip.12 Weighted values were inte-
grated into an overall estimate in kilopond (until April 1, 
1979) or Newton (after April 1, 1979). Test results were stan-
dardized against data from previous years, resulting in scores 
from 1 to 9 (low to high). Information on highest achieved 
parental education was derived from the longitudinal integra-
tion database for health insurance and labor market studies 
(Swedish acronym LISA). It includes all registered inhabitants 
from the age of 16 years (80% coverage) and is divided into 
7 levels: <9 years, pre–high school education of 9 years, high 
school education, university (<2 years), university (≥2 years), 
postgraduate education, and postgraduate research training.
Outcomes
The universal healthcare system in Sweden offers special-
ist hospital inpatient and outpatient care at low cost to all 
citizens. Data from visits or discharges are recorded in the 
Swedish National Hospital Register. Inpatient discharge data 
coverage increased gradually during the period of 1970 to 
1986 and is complete from 1987, with outpatient visits com-
plete from 2001. Cardiomyopathy cases, according to the 
International Classification of Diseases revisions 8 through 10, 
were identified through linkage to the Hospital Register and 
Cause of Death Register (Methods and Table I in the online-
only Data Supplement). Primary care data were not included 
in this study. Cardiomyopathy diagnoses were categorized as 
dilated cardiomyopathy, hypertrophic cardiomyopathy, alco-
hol/drug-induced cardiomyopathy, and other cardiomyopa-
thies (composed of less common forms). Cardiomyopathies 
with a prior myocardial infarction were considered heart dis-
ease of ischemic origin, censored at the date of diagnosis, and 
excluded from all analyses.
Statistical Analysis
Data were prepared with SAS version 9.4 (SAS Institute, Cary, 
NC), and statistical calculations were performed with R ver-
sion 3.4.2 (http://www.R-project.org). The follow-up period 
started at the date of conscription (baseline) and ended on 
December 31, 2014 (maximum, 9–46 years). Subjects were 
followed up until a first cardiomyopathy diagnosis, death, emi-
gration, myocardial infarction, or end of follow-up (December 
31, 2014), whichever occurred first. Incidence rates and cor-
responding 95% CIs were calculated with Poisson regres-
sion. Cox proportional hazards models were used to estimate 
cause-specific hazard ratios to assess the influence of BMI and 
presumptive predictors for cardiomyopathy. To avoid under-
estimating the true risk associated with high adolescent BMI, 
we refrained from adjusting for follow-up comorbidities such 
as coronary heart disease, diabetes mellitus, or hypertension, 
conditions that are strongly associated with an elevated BMI 
and constitute steps in the pathway toward heart failure. A 
sensitivity analysis was performed to study competing risk in 
which death was treated as a competing event. We used the 
Fine-Gray method for competing risk and coded fatal car-
diomyopathy events as cardiomyopathy events rather than 
deaths. BMI was categorized into 8 groups (<18.5, 18.5–<20, 
20–<22.5, 22.5–<25, 25–<27.5, 27.5–<30, 30–<35, and ≥35 
kg/m2). Systolic and diastolic blood pressures were each cate-
gorized into 5 groups (systolic: 100–119, 120–125, 126–130, 
131–138, and 139–180 mm Hg; diastolic: 40–59, 60–65, 66–
70, 71–76, and 77–100 mm Hg). Categorical variables were 
conscription test center, cardiorespiratory fitness, overall mus-
cle strength, and parental education. Cardiorespiratory fitness 
was trichotomized as low (1–4), moderate (5–7), or high (8 
and 9) and muscle strength as low (1–3), moderate (4–6), or 
high (7–9). Parental education was defined as low (pre–high 
school, ≤9 years), medium (high school, 10–12 years), or high 
(university and higher, >12 years). Differences among regions, 
examination years, and age at conscription were considered 
potential confounders, and we adjusted for them. Alcohol-
induced cardiomyopathy is a well-known condition,15 and 
alcohol/substance use disorders in adolescence were there-
fore included in the model. The proportionality assumption 
was tested with tests based on weighted residuals,16 and the 
models were stratified for variables not fulfilling the propor-
tionality criteria. Thus, the final models were stratified for year 
of conscription. Spline plots were generated with BMI as a 
restricted cubic spline with degree 3 and 4 knots placed at 
5% (18.0 kg/m2), 35% (20.5 kg/m2), 65% (22.4 kg/m2), and 
95% (27.5 kg/m2). Year of conscription was included in the 
spline with knots placed at 5% (1971), 35% (1982), 65% 
(1992), and 95% (2004). Interactions between BMI and other 
variables were tested in the BMI range >20 kg/m2 with BMI as 
a continuous variable. Systolic and diastolic blood pressures, 
cardiorespiratory fitness, and muscle strength were tested as 
continuous variables, and alcohol/substance use disorder was 
tested as a factor of 2 levels.
The Ethics Committee of the University of Gothenburg 
and Confidentiality Clearance at Statistics Sweden approved 
the study, and the investigation conforms to the principles 
outlined in the Declaration of Helsinki.
RESULTS
Study Population and Follow-Up
Of the 1 668 893 conscripts in the study (96% who were 
18 or 19 years of age; mean, 18.3 years; SD, 0.7 year), 
4477 were diagnosed with cardiomyopathy during fol-
low-up (median, 27 years; quartile 1–3, 19–35 years; 
44 346 736 person-years; Figure I in the online-only Data 
Supplement). The most common form was dilated car-
diomyopathy (59%, n=2631). There were 673 cases of 
hypertrophic cardiomyopathy and 480 cases of alcohol/
drug-induced cardiomyopathy (15% and 11%, respec-
tively). Only 4 cases of dilated, none of the hypertrophic, 
and 11 of the alcohol/drug-induced cardiomyopathies 
were diagnosed from the death registry alone, without 
prior hospitalization. Baseline data by BMI categories 
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are shown in Table 1; 79.6% of the men were normal 
weight (BMI, 18.5–<25 kg/m2), 10.0% were overweight 
(BMI, 25–<30 kg/m2), and 2.2% were obese, of whom 
7383 (0.4% of the study population) had a BMI of ≥35 
kg/m2. Blood pressure increased with increasing body 
weight. Cardiorespiratory fitness was highest in men 
with midrange BMI, whereas high muscle strength was 
much more common in obese compared with lean men. 
Overall, a low proportion (0.9%) of conscripts was iden-
tified with alcohol/substance use disorders.
Risk for Cardiomyopathy
Individuals with higher BMI were diagnosed with a car-
diomyopathy at a younger age compared with their lean-
er peers (Table 2). For each of the studied outcomes, the 
number of events, incidence rates per 100 000 observa-
tion years, and their corresponding confidence intervals 
by categories of BMI are presented in Table 2. Incidence 
rates for all categories of cardiomyopathies were slight-
ly J-shaped, ranging from a low of 4.7 cases of dilated 
cardiomyopathy per 100 000 person years in men with 
BMI of 20 to <22.5 kg/m2 to 24.7 for BMI ≥35 kg/m2; for 
hypertrophic cardiomyopathy, from a low of 1.2 among 
men with a BMI of 18.5≤BMI<20 to 3.3 among men with 
BMI 30≤BMI<35 kg/m2; for alcohol/drug-induced cardio-
myopathy, from 0.9 among men with BMI 20 to <22.5 kg/
m2 to 4.1 in the highest BMI category; and for other car-
diomyopathies, from 1.0 with a BMI of 18.5≤BMI<20 to 
3.1 among men with BMI 30≤BMI<35 kg/m2. The highest 
BMI category (BMI 35 kg/m2 and over) held very few cases 
for some categories. In comparison, corresponding rates 
were considerably higher for acute myocardial infarction 
at 45.8 to 88.3 and for heart failure at 8.0 to 48.8 (Table 
II in the online-only Data Supplement).
Starting at high-normal levels of BMI (22.5–<25 
kg/m2), the risk of dilated cardiomyopathy increased 
in a linear fashion compared with the BMI reference 
Table 1. Baseline Characteristics by BMI Category
All
BMI<18.5 
kg/m2
18.5 kg/m2 
≤BMI<20 
kg/m2
20 kg/m2 
≤BMI<22.5 
kg/m2
22.5 kg/m2 
≤BMI<25 
kg/m2
25 kg/m2 
≤BMI<27.5 
kg/m2
27.5 kg/m2 
≤BMI<30 
kg/m2
30 kg/m2 
≤BMI<35 
kg/m2
35 kg/m2 
≤BMI
Men, n (% of 
total)
1 668 893 
(100)
134 753 (8.1) 300 610 
(18.0)
673 394 (40.3) 355 486 
(21.3)
123 438 (7.4) 43 654 (2.6) 30 175 (1.8) 7383 (0.4)
Age, y 18.3 (0.7) 18.3 (0.6) 18.3 (0.6) 18.3 (0.6) 18.3 (0.7) 18.4 (0.8) 18.4 (0.8) 18.3 (0.8) 18.3 (0.7)
BMI, kg/m2 21.9 (3.0) 17.7 (0.67) 19.3 (0.42) 21.2 (0.71) 23.5 (0.69) 26.1 (0.73) 28.6 (0.68) 31.9 (1.36) 37.8 (2.66)
Systolic BP, 
mm Hg
129 (10.9) 126 (10.7) 127 (10.7) 128 (10.7) 130 (10.7) 131 (10.7) 133 (11.1) 134 (11.0) 136 (11.4)
Diastolic BP, 
mm Hg
67.6 (9.8) 67.4 (9.6) 67.2 (9.6) 67.3 (9.7) 67.7 (9.8) 68.4 (10.0) 69.3 (10.3) 70.4 (10.5) 72.6 (10.9)
Cardiorespiratory fitness, % (n)
  Low (1–4) 13.5 
(166 393)
33.5 (32 314) 17.4 (39 598) 9.0 (46 079) 7.8 (20 443) 14.4 (12 165) 27.2 (7354) 43.5 (6924) 62.7 (1516)
  Moderate 
(5–7)
58.7 
(722 393)
59.3 (57 153) 64.2 
(145 725)
57.8 (297 356) 56.2 
(147 846)
60.8 (51 395) 56.5 
(15 286)
43.8 (6971) 27.3 (661)
  High (8, 9) 27.8 
(341 927)
7.2 (6885) 18.4 (41 842) 33.2(170 793) 36.0 (94 720) 24.9 (21 013) 16.3 (4400) 12.8 (2032) 10.0 (242)
Muscle strength, % (n)
  Low (1–3) 13.8 
(150 192)
43.2 (39 568) 21.7 (43 854) 10.4 (45 573) 6.0 (13 692) 5.8 (4504) 6.3 (1711) 5.9 (1062) 6.6 (228)
  Moderate 
(4–6)
57.6 
(627 097)
54.2 (49 627) 68.4 
(138 565)
62.9 (276 925) 48.6 
(110 557)
41.9 (32 801) 39.4 
(10 721)
37.1 (6723) 34.3 (1178)
  High (7–9) 28.6 
(311 834)
2.6 (2398) 10.0 (20 176) 26.8 (117 765) 45.4 
(103 440)
52.3 (40 941) 54.3 (14 773) 57.0 (10 315) 59.0 (2026)
Parental education, % (n)
  Pre–high 
school (1, 2)
28.2 
(455 404)
31.5 (40 687) 29.4 (84 993) 27.5 (179 273) 27.1 (93 219) 28.4 (34 012) 29.6 
(12 536)
29.5 (8634) 28.4 (2050)
  High school 
(3, 4)
43.5 
(701 303)
42.3 (54 610) 42.3 
(12 2334)
42.7 (278 340) 44.1 
(152 026)
46.2 (55 241) 48.2 
(20 378)
49.8 (14 573) 52.7 (3801)
  University or 
higher (5–7)
28.3 
(455 631)
26.1 (33 699) 28.3 (81 990) 29.7 (193 492) 28.8 (99 300) 25.4 (30 314) 22.2 (9396) 20.8 (6080) 18.9 (1360)
Alcohol/
substance use 
disorder, % (n)
0.9 (14 449) 1.0 (1391) 1.0 (2872) 0.8 (5550) 0.8 (2871) 0.8 (1043) 0.9 (396) 0.8 (256) 0.9 (70)
Values are mean (SD) for continuous variables. BMI indicates body mass index; and BP, blood pressure.
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of 18.5 to <20 kg/m2 (Figure and Table 3), with a >8-
fold increased risk at BMI ≥35 kg/m2. For each 1-unit 
increase in BMI, the hazard ratio for dilated cardiomy-
opathy, adjusted for age at conscription, conscription 
year, test center, and baseline comorbidities, was 1.15 
(95% CI, 1.14–1.17), for hypertrophic cardiomyopa-
thy was 1.09 (95% CI, 1.06–1.12), and for alcohol/
drug-induced cardiomyopathy was 1.10 (95% CI, 
1.06–1.13; Table 3). Hazard ratios were largely simi-
lar in multiple-adjusted models additionally adjusted 
for systolic and diastolic blood pressures, cardiorespi-
ratory fitness, muscle strength, parental education, 
and alcohol/substance use disorders, based on fewer 
events because of missing data for some variables 
(Table 3 and Figure II in the online-only Data Supple-
ment). The hazard ratios did not change materially 
when we studied competing risk in which death was 
treated as a competing event (Table III in the online-
only Data Supplement). Corresponding rates for acute 
myocardial infarction and heart failure are presented 
in Table IV and Figure III in the online-only Data Sup-
plement. The relationships between BMI and dilated 
cardiomyopathy (nonischemic heart muscle disease) 
and between BMI and a diagnosis of cardiomyopathy 
with a prior myocardial infarction are shown in Figure 
IV in the online-only Data Supplement.
We found a graded association between diastolic 
blood pressure and dilated cardiomyopathy (Tables V and 
VI in the online-only Data Supplement). However, no as-
sociation was found between blood pressure and hyper-
trophic cardiomyopathy. Low cardiorespiratory fitness and 
low muscle strength were associated with increased risk 
of both dilated cardiomyopathy and alcohol/drug-induced 
cardiomyopathy. There was a >7-fold increased risk for a 
subsequent alcohol/drug-induced cardiomyopathy asso-
ciated with an alcohol/substance use disorder in adoles-
cence (Table VI in the online-only Data Supplement).
DISCUSSION
In this prospective cohort study of almost 1.7 million young 
men, elevated BMI in adolescence was associated with 
the development of cardiomyopathy in adulthood, with a 
steadily increasing risk from high-normal values and up to 
8-fold increase for dilated cardiomyopathy at BMI ≥35 kg/
m2. Other types of cardiomyopathies were also more com-
Table 2. Event Rates per 100 000 Observation-Years for Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy, Alcohol/Drug–Induced 
Cardiomyopathy, and Other Cardiomyopathies by BMI Category
All
BMI<18.5 
kg/m2
18.5 kg/m2 
≤BMI<20 
kg/m2
20 kg/m2 
≤BMI<22.5 
kg/m2
22.5 kg/m2 
≤BMI<25 
kg/m2
25 kg/m2 
≤BMI<27.5 
kg/m2
27.5 kg/m2 
≤BMI<30 
kg/m2
30 kg/m2 
≤BMI<35 
kg/m2
35 kg/
m2≤BMI
Men, n (% of total) 1 668 893 
(100)
134 753 (8.1) 300 610 
(18.0)
673 394 (40.3) 355 486 
(21.3)
123 438 (7.4) 43 654 (2.6) 30 175 (1.8) 7383 (0.4)
Age at 
cardiomyopathy 
diagnosis (SD), y
45.5 (9.3) 46.4 (9.0) 46.9 (9.0) 46.3 (9.4) 44.9 (9.5) 44.3 (9.0) 43.4 (9.2) 42.6 (9.2) 40.6 (8.6)
Follow-up time, 
median (Q1, Q3)
27 (19, 35) 30 (21, 38) 29 (20, 37) 27 (19, 35) 25 (18, 33) 24 (16, 32) 23 (15, 31) 21 (14, 29) 18 (12, 26)
Dilated cardiomyopathy
  Events, n (%) 2631 (0.16) 223 (0.17) 427 (0.14) 861 (0.13) 542 (0.15) 277 (0.22) 145 (0.33) 120 (0.40) 36 (0.49)
  Cases per 100 000 
observation-y 
(95% CI)
5.9 (5.7–6.2) 5.7 (5.0–6.5) 5.0 (4.6–5.5) 4.7 (4.4–5.1) 6.0 (5.5–6.5) 9.3 (8.2–10.4) 14.2  
(12.0–16.7)
18.0  
(14.9–21.5)
24.7  
(17.3–34.2)
Hypertrophic cardiomyopathy
  Events, n (%) 673 (0.04) 50 (0.04) 101 (0.03) 248 (0.04) 152 (0.04) 72 (0.06) 25 (0.06) 22 (0.07) 3 (0.04)
  Cases per 100 000 
observation-y 
(95% CI)
1.5 (1.4–1.6) 1.3 (1.0–1.7) 1.2 (1.0–1.4) 1.4 (1.2–1.5) 1.7 (1.4–2.0) 2.4 (1.9–3.0) 2.4 (1.6–3.6) 3.3 (2.1–5.0) 2.1 (0.4–6.0)
Alcohol/drug-induced cardiomyopathy
  Events, n (%) 480 (0.03) 45 (0.03) 89 (0.03) 172 (0.03) 106 (0.03) 35 (0.03) 16 (0.04) 11 (0.04) 6 (0.08)
  Cases per 100 000 
observation-y 
(95% CI)
1.1 (1.0–1.2) 1.2 (0.8–1.5) 1.1 (0.8–1.3) 0.9 (0.8–1.1) 1.2 (1.0–1.4) 1.2 (0.8–1.6) 1.6 (0.9–2.5) 1.6 (0.8–2.9) 4.1 (1.5–9.0)
Other cardiomyopathies
  Events, n (%) 538 (0.03) 49 (0.04) 88 (0.03) 195 (0.03) 125 (0.04) 37 (0.03) 21 (0.05) 21 (0.07) 2 (0.03)
  Cases per 100 000 
observation-y 
(95% CI)
1.2 (1.1–1.3) 1.3 (0.9–1.7) 1.0 (0.8–1.3) 1.1 (0.9–1.2) 1.4 (1.2–1.6) 1.2 (0.9–1.7) 2.1 (1.3–3.1) 3.1 (1.9–4.8) 1.4 (0.2–5.0)
BMI indicates body mass index; Q1, quartile 1; and Q3, quartile 3.
D
ow
nloaded from
 http://ahajournals.org by on June 14, 2019
Robertson et al Body Mass Index in Adolescence and Cardiomyopathy
xxx xxx, 2019 Circulation. 2019;139:00–00. DOI: 10.1161/CIRCULATIONAHA.118.0391326
OR
IG
IN
AL
 R
ES
EA
RC
H 
AR
TI
CL
E
mon in the obese and overweight categories. Additional 
factors measured in adolescence that were associated with 
long-term increased risk of cardiomyopathy were low car-
diorespiratory fitness and low muscle strength, although 
associations with BMI were independent of them.
Cardiomyopathies are a heterogeneous group of dis-
orders that are difficult to define and delimit, and com-
pared with other cardiovascular disorders, they are rela-
tively rare. Dilated cardiomyopathy is the most prevalent 
type,17 but the validity of a diagnosis of general or specif-
ic forms of cardiomyopathy needs to be established. In a 
recent study from our group in which we validated hos-
pital diagnoses of cardiomyopathy against predefined 
criteria and the use of echocardiography was nearly 
100% throughout the study period, diagnoses of dilat-
ed cardiomyopathy, hypertrophic cardiomyopathy, and 
other cardiomyopathies were found to be accurate in 
86%, 88%, and 100% of cases, respectively.4 Although 
that study included 3 hospitals in different settings, in 
3 cities, and in an unselected population covering a 
large part of western Sweden, there were no significant 
changes in accuracy between the hospitals or over the 
extended study period of 20 years. Furthermore, of the 
individuals with dilated and alcohol-associated cardio-
myopathies in the present study, 69% were diagnosed 
with heart failure at some point, but the absence of a 
heart failure diagnosis does not exclude the presence of 
symptoms, and clinical heart failure is not a prerequisite 
for a diagnosis of cardiomyopathy. Men with a diagno-
sis of hypertrophic cardiomyopathy received a diagnosis 
of heart failure much less often (11%), whereas among 
men without a diagnosis of cardiomyopathy, only 0.8% 
were diagnosed with heart failure.
Few studies have described the epidemiology of car-
diomyopathies,17–20 and risk factors for these disorders 
remain a largely unexplored field. The present cohort 
study adds to the literature by investigating BMI in late 
adolescence and identifying a large number of cardio-
myopathy cases over an extended follow-up. This pro-
vides an opportunity to identify adolescent men who are 
at an elevated risk not only for cardiomyopathy but also 
for a range of other disorders associated with obesity,10 
particularly because cardiovascular risk factors, including 
overweight and obesity, tend to cluster and track from 
childhood into adulthood.21,22 The 1 existing relevant 
study that we identified,10 based on a cohort of 2.3 mil-
lion Israeli adolescents and identifying 121 deaths attrib-
uted to cardiomyopathies, also found a graded increase 
in risk with increasing BMI. This study, however, was not 
powered to investigate specific forms of cardiomyopa-
thy or the association with severe obesity, or BMI ≥35 
kg/m2, which forms an increasing proportion among the 
overweight in Sweden.11 We found an 8-fold increase 
in risk for dilated cardiomyopathy at BMI ≥35 kg/m2. 
Figure. Association between body mass index (BMI) at conscription and risk for cardiomyopathy (CM).  
The model was adjusted for age, conscription year (as a spline with knots at 5%, 35%, 65%, and 95%, ie, 1971, 1982, 1992, and 2004), test center, and baseline 
comorbidities (diabetes mellitus, hypertension, congenital heart disease), systolic blood pressure, diastolic blood pressure, cardiorespiratory fitness, muscle strength, 
parental education, and alcohol or substance use disorder (n=773 679). BMI was restricted to BMI between 15 and 40 kg/m2 and modeled as a restricted cubic 
spline with knots at 5%, 35%, 65%, and 95% (ie, 18.0, 20.5, 22.4, and 27.5 kg/m2), with BMI of 20 kg/m2 as reference. The unadjusted model is presented in 
Figure II in the online-only Data Supplement.D
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Globally, the rising trends in children’s and adolescents’ 
BMIs have plateaued in many high-income countries,9 
but levels remain disturbingly high, and accordingly, this 
could herald a future global epidemic of obesity-related 
heart conditions in the young and middle-aged.
Estimating the association between obesity and car-
diovascular risk is complicated because of the strong 
association between elevated body weight and other 
cardiovascular risk factors such as hypertension, diabe-
tes mellitus, and dyslipidemias.23 Young people might 
not yet have accumulated these risk factors, and ac-
cordingly, they are an optimal study population in this 
regard. Childhood obesity has, however, independently 
been associated with significant changes in myocar-
dial geometry and function,24 which has been further 
strengthened in a study of obesity genes in young 
adults,25 indicating an early onset of potentially unfa-
vorable alterations in the myocardium that are indepen-
dent of other cardiovascular risk factors. In this study, 
we found that the risk of cardiomyopathy started to 
increase at levels of adolescent BMI at the upper nor-
mal level, which is in accordance with recent findings 
with respect to early heart failure7 and is supported by 
the findings by Twig et al.10 In studies of people with 
severe obesity, cardiomyopathy has been identified as 
a complication,26,27 with severity and duration of obe-
sity recognized as essential determinants of alterations 
in cardiac performance and morphology.28 The devel-
opment and progression of myocardial remodeling in 
obese subjects are predisposed by multiple mecha-
nisms, including hemodynamic alterations such as in-
creased blood volume and cardiac output, leading to 
left ventricular hypertrophy and dilation. Indeed, obe-
sity appears to be an underrecognized driver of ad-
verse cardiac remodeling and heart failure, as recently 
argued.29 Altered lipid metabolism, including overac-
tivity of adipocyte cell–signaling molecules such as al-
dosterone, neprilysin, and leptin,30 inflammation, and 
oxidative stress, has been described as contributing to 
these effects, potentially resulting in cardiac fibrosis 
Table 3. Hazard Ratios (95% CIs) for Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy, Alcohol/Drug-Induced 
Cardiomyopathy, and Other Cardiomyopathies by BMI Category
Dilated 
Cardiomyopathy
Hypertrophic 
Cardiomyopathy
Alcohol/Drug-Induced 
Cardiomyopathy
Other 
Cardiomyopathies
Model 1*
  Events/population, n 2631/1 668 781 673/1 668 781 480/1 668 781 538/1 668 781
  BMI<18.5 kg/m2 1.07 (0.91–1.26) 1.04 (0.74–1.46) 1.04 (0.73–1.49) 1.19 (0.84–1.68)
  18.5 kg/m2≤BMI<20 kg/m2 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
  20 kg/m2≤BMI<22.5 kg/m2 1.01 (0.90–1.13) 1.20 (0.95–1.51) 0.97 (0.75–1.26) 1.06 (0.83–1.37)
  22.5 kg/m2≤BMI<25 kg/m2 1.38 (1.22–1.57) 1.55 (1.21–2.00) 1.31 (0.99–1.74) 1.41 (1.07–1.85)
  25 kg/m2≤BMI<27.5 kg/m2 2.26 (1.94–2.63) 2.31 (1.70–3.12) 1.40 (0.95–2.07) 1.28 (0.87–1.89)
  27.5 kg/m2≤BMI<30 kg/m2 3.65 (3.02–4.41) 2.41 (1.55–3.74) 2.00 (1.17–3.41) 2.17 (1.35–3.50)
  30 kg/m2≤BMI<35 kg/m2 5.03 (4.10–6.17) 3.39 (2.13–5.40) 2.34 (1.25–4.39) 3.40 (2.11–5.50)
  35 kg/m2≤BMI 8.11 (5.76–11.43) 2.28 (0.72–7.22) 7.22 (3.14–16.58) 1.55 (0.38–6.33)
  Per unit BMI† 1.15 (1.14–1.17) 1.09 (1.06–1.12) 1.10 (1.06–1.13) 1.08 (1.05–1.12)
Model 2‡
  Events/population, n 1553/773 805 360/773 805 280/773 805 292/773 805
  BMI<18.5 kg/m2 0.85 (0.69–1.06) 1.02 (0.64–1.61) 0.77 (0.48–1.24) 1.08 (0.67–1.75)
  18.5 kg/m2≤BMI<20 kg/m2 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
  20 kg/m2≤BMI<22.5 kg/m2 1.13 (0.97–1.31) 1.31 (0.96–1.81) 0.95 (0.68–1.32) 0.97 (0.69–1.36)
  22.5 kg/m2≤BMI<25 kg/m2 1.56 (1.32–1.85) 1.75 (1.22–2.51) 1.66 (1.15–2.41) 1.24 (0.84–1.83)
  25 kg/m2≤BMI<27.5 kg/m2 2.35 (1.90–2.89) 3.06 (2.00–4.68) 1.60 (0.94–2.75) 1.09 (0.63–1.91)
  27.5 kg/m2≤BMI<30 kg/m2 3.13 (2.36–4.16) 3.03 (1.60–5.75) 2.20 (1.03–4.70) 2.32 (1.21–4.43)
  30 kg/m2≤BMI<35 kg/m2 4.91 (3.64–6.61) 3.17 (1.42–7.07) 1.96 (0.70–5.49) 3.38 (1.68–6.81)
  35 kg/m2≤BMI 9.35 (5.60–15.62) 3.28 (0.45–23.90) 9.56 (2.91–31.37) 4.67 (1.12–19.48)
  Per unit BMI† 1.15 (1.13–1.17) 1.11 (1.07–1.16) 1.11 (1.06–1.17) 1.11 (1.07–1.17)
BMI indicates body mass index.
*Model 1 adjusted for age at conscription, conscription year, test center, and baseline comorbidities (diabetes mellitus, hypertension, congenital 
heart disease). 
†Calculated for BMI >20 kg/m2. 
‡Model 2 additionally adjusted for systolic blood pressure, diastolic blood pressure, cardiorespiratory fitness, muscle strength, parental 
education, and alcohol or substance use disorder.
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and impaired diastolic and systolic function.31 All the 
specific categories of cardiomyopathy that we identi-
fied showed an association with body weight, although 
that association is strongest for dilated cardiomyopathy. 
How increasing BMI causes the observed associations 
cannot be answered from these data. Although part of 
the answer may relate to myocardial effects of excess 
fat, this would not be expected to increase the risk for 
true hypertrophic cardiomyopathy, which is a hereditary 
condition in most cases. Instead it may be that elevated 
BMI leads to hypertrophy as a result of increased left 
ventricular wall stress related to volume and pressure 
overload, caused by hypertension, blood volume ex-
pansion, and increased myocardial work. In these ways, 
higher BMI might lead to earlier symptomatic expres-
sion and therefore a diagnosis of cardiomyopathy (and 
exacerbate other deficits in cardiac function, leading 
to premature decompensation). It is also known that 
obesity and alcohol intake synergize to increase risks of 
several complications such as liver diseases,32 and the 
same may be true for cardiomyopathy. Because alcohol 
abuse and substance abuse are important independent 
reversible causes of myocardial dysfunction,15 we treat-
ed them as a separate group, but even so, there was 
still a strong association with overweight and obesity.
Associations between blood pressure in adolescence 
and cardiomyopathy were either nonsignificant or weak. 
The positive association between elevated diastolic blood 
pressure and risk of dilated cardiomyopathy was much 
less strong than that found for BMI and was notably 
absent for hypertrophic cardiomyopathy. Although fur-
ther development with respect to hypertension during 
follow-up is not known, this indicates that the hypertro-
phy was likely not caused by hypertension, a distinction 
that is sometimes difficult to make in clinical practice. Ex-
cept for BMI, hypertrophic cardiomyopathy did not have 
identifiable risk factors to the same extent as the other 
categories, probably because of the strong genetic com-
ponent associated with this type of cardiomyopathy.3
Strengths and Limitations
Strengths of this study include the large sample size 
(>1.6 million participants), the prospective popula-
tion-based design, and the fact that the study pop-
ulation is largely representative of the male general 
population in these age categories in Sweden during 
the study period. A large number of cases of cardio-
myopathies were recorded during an extended fol-
low-up. Recent data from a validation study by our 
group showed that the cardiomyopathy diagnoses in 
the National Hospital Register, during a period over-
lapping that of the present study, have a high validity 
with a diagnostic accuracy of >85%, with no change 
in diagnostic accuracy over the 20-year study period 
and with a more or less uniform use of echocardiog-
raphy in the investigation of suspected cardiomyopa-
thy throughout these years.
There are also some limitations to our study. We used 
BMI as an indicator of overweight and obesity. Mildly 
elevated BMI in youth may reflect high muscle mass, 
not adiposity, which, however, is unlikely to be the case 
when BMI is very high. We also observed increasing risks 
from high-normal BMI, and when we adjusted for mus-
cle strength, the association between BMI and cardio-
myopathy was only slightly attenuated. Other measure-
ments such as waist circumference, waist-to-hip ratio, 
or any other anthropometric variable beyond BMI were 
not available in the data set. The study population was 
homogeneous with respect to age, sex, and ethnicity, 
which limits the generalizability to women and to other 
populations. Immigration increased over the period, 
but the effect of ethnicity could not be systematically 
assessed because of a lack of detailed data. Further-
more, the diagnostic criteria for cardiomyopathy have 
changed over time. Limited diagnostic criteria over the 
initial follow-up indicate that some patients with cardio-
myopathy according to the 2008 guidelines might not 
have been identified. In addition, we were unable to 
study some other potentially important exposures such 
as weight gain or loss, smoking habits, diet, physical ac-
tivity, occupation, alcohol consumption, and substance 
abuse during follow-up. Hence, there is no way to know 
if subsequent weight changes would affect the risk.
CONCLUSIONS
This cohort study adds to the literature by identifying ele-
vated BMI in adolescence to be associated with a diagno-
sis of cardiomyopathy in adulthood, especially dilated car-
diomyopathy. The already marked importance of weight 
control in youth is further strengthened by these findings, 
as well as greater evidence for obesity as a potential im-
portant cause of adverse cardiac remodeling that is inde-
pendent of clinically evident ischemic heart disease.
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